Medicine and Dentistry
Endometriosis
100%
Etonogestrel
100%
Lesion
83%
Fibroblast Growth Factor Receptor
66%
Estrus Cycle
66%
Growth
50%
Therapeutic Procedure
33%
Uterus
33%
Quantitative Reverse Transcription Polymerase Chain Reaction
33%
Day of Surgery
33%
Gene Expression
16%
Cells
16%
Surgery
16%
Cyst
16%
Pathophysiology
16%
Donor
16%
Chronic Disease
16%
Receptor Gene
16%
Gestagen
16%
Peritoneal Cavity
16%
Proestrus
16%
Hyperaemia
16%
Biochemistry, Genetics and Molecular Biology
Etonogestrel
100%
Fibroblast Growth Factor Receptor
66%
Estrus Cycle
66%
Growth
50%
Mouse
33%
Mouse Model
33%
Growth Factor Receptor Inhibitor
33%
Gene Expression
16%
Dose
16%
Weight
16%
Receptor Gene
16%
Proestrus
16%
Pharmacology, Toxicology and Pharmaceutical Science
Etonogestrel
100%
Endometriosis
100%
Fibroblast Growth Factor Receptor
66%
Mouse
33%
Mouse Model
33%
Pathophysiology
16%
Chronic Disease
16%
Progestin
16%
Hyperemia
16%
Cyst
16%
Veterinary Science and Veterinary Medicine
Endometriosis
100%
Etonogestrel
100%
Growth Factor Receptor Inhibitor
33%
Peritoneal Cavity
16%
Progestin
16%
Uterine Cavity
16%
Agricultural and Biological Sciences
Etonogestrel
100%
Fibroblast Growth Factor Receptor
66%
Mice
33%
Cells
16%
Gene Expression
16%
Weight
16%
Progestogen
16%
Proestrus
16%